Insight into nanoparticle cellular uptake and intracellular targeting

Journal of Controlled Release

Volumn 190, Issue , 2014, Pages 485-499

  Yameen, Basit ^a   Choi, Won Il ^a   Vilos, Cristian ^a,b   Swami, Archana ^a   Shi, Jinjun ^a   Farokhzad, Omid C ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Intracellular distribution; Nanomedicine; Nanoparticle cellular uptake; Non targeted and targeted nanoparticles; Subcellular targeting

Indexed keywords

CELL MEMBRANES; LIGANDS; NANOPARTICLES;

CELLULAR INTERNALIZATION; CELLULAR UPTAKE; INTRACELLULAR DISTRIBUTION; INTRACELLULAR LOCALIZATION; INTRACELLULAR TARGETING; SUBCELLULAR COMPARTMENTS; SUBCELLULAR TARGETING; TARGETED NANOPARTICLE;

MEDICAL NANOTECHNOLOGY;

CLATHRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FOLATE RECEPTOR; INTEGRIN; LIGAND; NANOPARTICLE; NEONATAL FC RECEPTOR; PROSTATE SPECIFIC MEMBRANE ANTIGEN; RECEPTOR; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; DRUG; DRUG CARRIER; POLYMER; FC RECEPTOR;

ARTICLE; CANCER CELL; CAVEOLA; CELL NUCLEUS; CELL TRANSPORT; CELLULAR UPTAKE; CYTOPLASM; DRUG DELIVERY SYSTEM; ENDOPLASMIC RETICULUM; ENDOSOME; GOLGI COMPLEX; HUMAN; INTERNALIZATION; INTESTINAL EPITHELIAL BARRIER; INTESTINE EPITHELIUM CELL; INTRACELLULAR SIGNALING; LIGAND BINDING; LYSOSOME; MITOCHONDRION; NANOMEDICINE; NONHUMAN; NUTRIENT UPTAKE; PERMEABILITY BARRIER; PHAGOCYTOSIS; PINOCYTOSIS; PRIORITY JOURNAL; RECEPTOR BINDING; TARGET CELL; CELLS; CHEMISTRY; GENE EXPRESSION; INTRACELLULAR SPACE; METABOLISM; PHARMACOKINETICS; PROCEDURES; SYNTHESIS; CELL MIGRATION; CELLULAR DISTRIBUTION; ENDOCYTOSIS; PROTEIN TARGETING; REVIEW;

CELLS; DRUG CARRIERS; GENE EXPRESSION; HUMANS; INTRACELLULAR SPACE; NANOMEDICINE; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; POLYMERS;

EID: 84906781767     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.06.038     Document Type: Review

References (211)

1. N. Kamaly, Z. Xiao, P.M. Valencia, A.F. Radovic-Moreno, and O.C. Farokhzad Targeted polymeric therapeutic nanoparticles: design, development and clinical translation Chem. Soc. Rev. 41 2012 2971 3010
2. R.P. Feynman There's plenty of room at the bottom Eng. Sci. (CalTech) 23 1960 22 36
3. P. Ehrlich Address in pathology, on chemotherapy, delivered before the 17th Intl. Congress Med. Br. Med. J. 16 1913 353 359
4. K. Strebhardt, and A. Ullrich Paul Ehrlich's magic bullet concept: 100 years of progress Nat. Rev. Cancer 8 2008 473 480 (Pubitemid 351752547)
5. R. Mout, D.F. Moyano, S. Rana, and V.M. Rotello Surface functionalization of nanoparticles for nanomedicine Chem. Soc. Rev. 41 2012 2539 2544
6. M. Elsabahy, and K.L. Wooley Design of polymeric nanoparticles for biomedical delivery applications Chem. Soc. Rev. 41 2012 2545 2561
7. E.C. Dreaden, A.M. Alkilany, X. Huang, C.J. Murphy, and M.A. El-Sayed The golden age: gold nanoparticles for biomedicine Chem. Soc. Rev. 41 2012 2740 2779
8. J. Khandare, M. Calderón, N.M. Dagia, and R. Haag Multifunctional dendritic polymers in nanomedicine: opportunities and challenges Chem. Soc. Rev. 41 2012 2824 2848
9. Z. Zhang, S. Chen, and S. Jiang Dual-functional biomimetic materials: nonfouling poly(carboxybetaine) with active functional groups for protein immobilization Biomacromolecules 7 2006 3311 3315 (Pubitemid 46111784)
10. L. Zhang, Z. Cao, T. Bai, L. Carr, J.-R. Ella-Menye, C. Irvin, B.D. Ratner, and S. Jiang Zwitterionic hydrogels implanted in mice resist the foreign-body reaction Nat. Biotechnol. 31 2013 553 556
11. N. Bertrand, J. Wu, X. Xu, N. Kamaly, and O.C. Farokhzad Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology Adv. Drug Deliv. Rev. 66 2014 2 25
12. T.M. Allen, and A. Chonn Large unilamellar liposomes with low uptake into the reticuloendothelial system FEBS Lett. 223 1987 42 46
13. H. Maeda Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects Bioconjug. Chem. 21 2010 797 802
14. U. Prabhakar, D.C. Blakey, H. Maeda, R.K. Jain, E.M. Sevick-Muraca, W. Zamboni, O.C. Farokhzad, S.T. Barry, A. Gabizon, and P. Grodzinski Challenges and key considerations of the enhanced permeability and retention effect (EPR) for nanomedicine drug delivery in oncology Cancer Res. 73 2013 2412 2417
15. A.R. Reynolds, S. Moein Moghimi, and K. Hodivala-Dilke Nanoparticle-mediated gene delivery to tumour neovasculature Trends Mol. Med. 9 2003 2 4 (Pubitemid 36139248)
16. J. Folkman Angiogenesis Annu. Rev. Med. 57 2006 1 18 (Pubitemid 43261975)
17. J. Shi, Z. Xiao, N. Kamaly, and O.C. Farokhzad Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation Acc. Chem. Res. 44 2011 1123 1134
18. J. Hrkach, D. Von Hoff, M.M. Ali, E. Andrianova, J. Auer, T. Campbell, D. DeWitt, M. Figa, M. Figueiredo, A. Horhota, S. Low, K. McDonnell, E. Peeke, B. Retnajaran, A. Sabnis, E. Schnipper, J.J. Song, Y.H. Song, J. Summa, D. Tompsett, G. Troiano, T. Van Geen Hoven, J. Wright, P. LoRusso, P.W. Kantoff, N.H. Bander, C. Sweeney, O.C. Farokhzad, R. Langer, and S. Zale Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile Sci. Transl. Med. 4 2012 128 139
19. D.W. Bartlett, H. Su, I.J. Hildebrandt, W.A. Weber, and M.E. Davis Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging Proc. Natl. Acad. Sci. U. S. A. 104 2007 15549 15554 (Pubitemid 47502954)
20. L. Rajendran, H.-J. Knölker, and K. Simons Subcellular targeting strategies for drug design and delivery Nat. Rev. Drug Discov. 9 2010 29 42
21. J.G. Huang, T. Leshuk, and F.X. Gu Emerging nanomaterials for targeting subcellular organelles Nano Today 6 2011 478 492
22. B.Y. Kim, J.T. Rutka, and W.C. Chan Nanomedicine N. Engl. J. Med. 363 2010 2434 2443
23. V.P. Chauhan, and R.K. Jain Strategies for advancing cancer nanomedicine Nat. Mater. 12 2013 958 962
24. G.J. Doherty, and H.T. McMahon Mechanisms of endocytosis Annu. Rev. Biochem. 78 2009 857 902
25. R.M. Steinman, I.S. Mellman, W.A. Muller, and Z.A. Cohn Endocytosis and the recycling of plasma membrane J. Cell Biol. 96 1983 1 27 (Pubitemid 13155557)
26. A. Aderem, and D.M. Underhill Mechanisms of phagocytosis in macrophages Annu. Rev. Immunol. 17 1999 593 623 (Pubitemid 29241135)
27. S.C. Silverstein Phagocytosis of microbes: insights and prospects Trends Cell Biol. 5 1995 141 142
28. M. Rabinovitch Professional and non-professional phagocytes: an introduction Trends Cell Biol. 5 1995 85 87
29. D.E. Owens, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102 (Pubitemid 41773257)
30. D.M. Underhill, and H.S. Goodridge Information processing during phagocytosis Nat. Rev. Immunol. 12 2012 492 502
31. J.A. Champion, and S. Mitragotri Shape induced inhibition of phagocytosis of polymer particles Pharm. Res. 26 2009 244 249
32. J.A. Champion, and S. Mitragotri Role of target geometry in phagocytosis Proc. Natl. Acad. Sci. U. S. A. 103 2006 4930 4934
33. Y. Geng, P. Dalhaimer, S. Cai, R. Tsai, M. Tewari, T. Minko, and D.E. Discher Shape effects of filaments versus spherical particles in flow and drug delivery Nat. Nanotechnol. 2 2007 249 255 (Pubitemid 46739812)
34. S. Harguindey, J.L. Arranz, M.L. Wahl, G. Orive, and S.J. Reshkin Proton transport inhibitors as potentially selective anticancer drugs Anticancer Res. 29 2009 2127 2136
35. T. Kirchhausen, and Clathrin Ann. Rev. Biochem. 69 2000 699 727
36. M.G. Ford, I.G. Mills, B.J. Peter, Y. Vallis, G.J. Praefcke, P.R. Evans, and H.T. McMahon Curvature of clathrin-coated pits driven by epsin Nature 419 2002 361 366
37. B.J. Peter, H.M. Kent, I.G. Mills, Y. Vallis, P.J. Butler, P.R. Evans, and H.T. McMahon BAR domains as sensors of membrane curvature: the amphiphysin BAR structure Science 303 2004 495 499 (Pubitemid 38120842)
38. B.R. Capraro, Z. Shi, T. Wu, Z. Chen, J.M. Dunn, E. Rhoades, and T. Baumgart Kinetics of endophilin N-BAR domain dimerization and membrane interactions J. Biol. Chem. 288 2013 12533 12543
39. W.M. Henne, H.M. Kent, M.G. Ford, B.G. Hegde, O. Daumke, P.J. Butler, R. Mittal, R. Langen, P.R. Evans, and H.T. McMahon Structure and analysis of FCHo2 F-BAR domain: a dimerizing and membrane recruitment module that effects membrane curvature Structure 15 2007 839 852 (Pubitemid 47042426)
40. E. Cocucci, F. Aguet, S. Boulant, and T. Kirchhausen The first five seconds in the life of a clathrin-coated pit Cell 150 2012 495 507
41. P.A. Vanlandingham, M.P. Barmchi, S. Royer, R. Green, H. Bao, N. Reist, and B. Zhang AP180 couples protein retrieval to clathrin-mediated endocytosis of synaptic vesicles Traffic 15 2014 433 450
42. F. Tebar, S.K. Bohlander, and A. Sorkin Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic Mol. Biol. Cell 10 1999 2687 2702 (Pubitemid 29393520)
43. E.M. Schmid, and H.T. McMahon Integrating molecular and network biology to decode endocytosis Nature 448 2007 883 888 (Pubitemid 47312770)
44. M. Marsh, and H.T. McMahon The structural era of endocytosis Science 285 1999 215 220 (Pubitemid 29329987)
45. M.H. Stowell, B. Marks, P. Wigge, and H.T. McMahon Nucleotide-dependent conformational changes in dynamin: evidence for a mechanochemical molecular spring Nat. Cell Biol. 1 1999 27 32 (Pubitemid 129495006)
46. H.T. McMahon, and E. Boucrot Molecular mechanism and physiological functions of clathrin-mediated endocytosis Nat. Rev. Mol. Cell Biol. 12 2011 517 533
47. O. Harush-Frenkel, N. Debotton, S. Benita, and Y. Altschuler Targeting of nanoparticles to the clathrin-mediated endocytic pathway Biochem. Biophys. Res. Commun. 353 2007 26 32 (Pubitemid 44958337)
48. J.K. Vasir, and V. Labhasetwar Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles Biomaterials 29 2008 4244 4252
49. D.-M. Huang, Y. Hung, B.-S. Ko, S.-C. Hsu, W.-H. Chen, C.-L. Chien, C.-P. Tsai, C.-T. Kuo, J.-C. Kang, C.-S. Yang, C.-Y. Mou, and Y.-C. Chen Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking FASEB J. 19 2005 2014 2016 (Pubitemid 41759749)
50. K. Sandvig, M.L. Torgersen, H.A. Raa, and B. van Deurs Clathrin-independent endocytosis: from nonexisting to an extreme degree of complexity Histochem. Cell Biol. 129 2008 267 276
51. A.S. Robertson, E. Smythe, and K.R. Ayscough Functions of actin in endocytosis Cell. Mol. Life Sci. 66 2009 2049 2065
52. K. Sandvig, S. Pust, T. Skotland, and B. van Deurs Clathrin-independent endocytosis: mechanisms and function Curr. Opin. Cell Biol. 23 2011 413 420
53. H. Radhakrishna, and J.G. Donaldson ADP-ribosylation factor 6 regulates a novel plasma membrane recycling pathway J. Cell Biol. 139 1997 49 61 (Pubitemid 27444080)
54. A.M. Powelka, J. Sun, J. Li, M. Gao, L.M. Shaw, A. Sonnenberg, and V.W. Hsu Stimulation-dependent recycling of integrin beta1 regulated by ARF6 and Rab11 Traffic 5 2004 20 36 (Pubitemid 38159401)
55. C.A. Eyster, J.D. Higginson, R. Huebner, N. Porat-Shliom, R. Weigert, W.W. Wu, R.F. Shen, and J.G. Donaldson Discovery of new cargo proteins that enter cells through clathrin-independent endocytosis Traffic 10 2009 590 599
56. C. Lamaze, A. Dujeancourt, T. Baba, C.G. Lo, A. Benmerah, and A. Dautry-Varsat Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway Mol. Cell 7 2001 661 671 (Pubitemid 32706357)
57. A. Llorente, A. Rapak, S.L. Schmid, B. van Deurs, and K. Sandvig Expression of mutant dynamin inhibits toxicity and transport of endocytosed ricin to the Golgi apparatus J. Cell Biol. 140 1998 553 563 (Pubitemid 28134059)
58. N.C. Gauthier, P. Monzo, V. Kaddai, A. Doye, V. Ricci, and P. Boquet Helicobacter pylori VacA cytotoxin: a probe for a clathrin-independent and Cdc42-dependent pinocytic pathway routed to late endosomes Mol. Biol. Cell 16 2005 4852 4866 (Pubitemid 41416465)
59. B.D. Grant, and J.G. Donaldson Pathways and mechanisms of endocytic recycling Nat. Rev. Mol. Cell Biol. 10 2009 597 608
60. Z. Garaiova, S.P. Strand, N.K. Reitan, S. Lélu, S.E. Størset, K. Berg, J. Malmo, O. Folasire, A. Bjørkøy, and C. de L. Davies Cellular uptake of DNA-chitosan nanoparticles: the role of clathrin- and caveolae-mediated pathways Int. J. Biol. Macromol. 51 2012 1043 1051
61. E.M. Plummer, and M. Manchester Endocytic uptake pathways utilized by CPMV nanoparticles Mol. Pharm. 10 2013 26 32
62. S. Lerch, M. Dass, A. Musyanovycha, K. Landfester, and V. Mailänder Polymeric nanoparticles of different sizes overcome the cell membrane barrier Eur. J. Pharm. Biopharm. 84 2013 265 274
63. Z. Garaiova, S.P. Strand, N.K. Reitan, S. Lélu, S. Størset, K. Berg, J. Malmo, O. Folasire, A. Bjørkøy, and C. de L. Davies Cellular uptake of DNA-chitosan nanoparticles: the role of clathrin- and caveolae-mediated pathways Int. J. Biol. Macromol. 51 2012 1043 1051
64. R.G. Parton, and K. Simons The multiple faces of caveolae Nat. Rev. Mol. Cell Biol. 8 2007 185 194
65. H. Thorn, K.G. Stenkula, M. Karlsson, U. Ortegren, F.H. Nystrom, J. Gustavsson, and P. Stralfors Cell surface orifices of caveolae and localization of caveolin to the necks of caveolae in adipocytes Mol. Biol. Cell 14 2003 3967 3976 (Pubitemid 37186301)
66. Z. Wang, C. Tiruppathi, J. Cho, R.D. Minshall, and A.B. Malik Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae IUBMB Life 63 2011 659 667
67. L. Pelkmans, and M. Zerial Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae Nature 436 2005 128 133 (Pubitemid 40966198)
68. R.G. Parton, and M.A. del Pozo Caveolae as plasma membrane sensors, protectors and organizers Nat. Rev. Mol. Cell Biol. 14 2013 98 112
69. P. Oh, P. Borgstrom, H. Witkiewicz, Y. Li, B.J. Borgstrom, A. Chrastina, K. Iwata, K.R. Zinn, R. Baldwin, J.E. Testa, and J.E. Schnitzer Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung Nat. Biotechnol. 25 2007 327 337 (Pubitemid 46398772)
70. Y. Liu, R. Huang, and L. Han et al. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles Biomaterials 30 2009 4195 4202
71. M. Lafon Rabies virus receptors J. Neurovirol. 11 2005 82 87 (Pubitemid 40458377)
72. S. Falcone, E. Cocucci, P. Podini, T. Kirchhausen, E. Clementi, and J. Meldolesi Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events J. Cell Sci. 119 2006 4758 4769 (Pubitemid 44964272)
73. C. Fiorentini, L. Falzano, A. Fabbri, A. Stringaro, M. Logozzi, S. Travaglione, S. Contamin, G. Arancia, W. Malorni, and S. Fais Activation of rho GTPases by cytotoxic necrotizing factor 1 induces macropinocytosis and scavenging activity in epithelial cells Mol. Biol. Cell 12 2001 2061 2073 (Pubitemid 33049699)
74. J. Mercer, and A. Helenius Virus entry by macropinocytosis Nat. Cell Biol. 11 2009 510 520
75. A. Kolb-Maurer, M. Wilhelm, F. Weissinger, E.B. Brocker, and W. Goebel Interaction of human hematopoietic stem cells with bacterial pathogens Blood 100 2002 3703 3709 (Pubitemid 35303942)
76. R.M. Steinman, and J. Swanson The endocytic activity of dendritic cells J. Exp. Med. 182 1995 283 288
77. F. Sallusto, M. Cella, C. Danieli, and A. Lanzavecchia Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products J. Exp. Med. 182 1995 389 400
78. M.C. Kerr, and R.D. Teasdale Defining macropinocytosis Traffic 10 2009 364 371
79. D.A. Schafer, C. D'Souza-Schorey, and J.A. Cooper Actin assembly at membranes controlled by ARF6 Traffic 1 2000 892 903
80. C. Nobes, and M. Marsh Dendritic cells: new roles for Cdc42 and Rac in antigen uptake? Curr. Biol. 10 2000 R739 R741
81. M.A. West, M.S. Bretscher, and C. Watts Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells J. Cell Biol. 109 1989 2731 2739 (Pubitemid 20011900)
82. E.L. Racoosin, and J.A. Swanson Macropinosome maturation and fusion with tubular lysosomes in macrophages J. Cell Biol. 121 1993 1011 1020 (Pubitemid 23154262)
83. S.E.A. Gratton, P.A. Ropp, P.D. Pohlhaus, J.C. Luft, V.J. Madden, M.E. Napier, and J.M. DeSimone The effect of particle design on cellular internalization pathways Proc. Natl. Acad. Sci. 105 2008 11613 11618
84. L. Zhang, S. Zhang, S-b. Ruan, Q-y. Zhang, Q. He, and H-l. Gao Lapatinib-incorporated lipoprotein-like nanoparticles: preparation and a proposed breast cancer-targeting mechanism Acta Pharmacol. Sin. 35 2014 846 852
85. E. Reboul Absorption of vitamin A and carotenoids by the enterocyte: focus on transport proteins Nutrients 5 2013 3563 3581
86. T. Yuan, S. Hong, Y. Yao, and K. Liao Glut-4 is translocated to both caveolae and non-caveolar lipid rafts, but is partially internalized through caveolae in insulin-stimulated adipocytes Cell Res. 17 2007 772 782 (Pubitemid 47409702)
87. M.M. Hussain Intestinal lipid absorption and lipoprotein formation Curr. Opin. Lipidol. 2014 10.1097/MOL.0000000000000084
88. Q. Wang, K.A. Beaumont, N.J. Otte, J. Font, C.G. Bailey, M. van Geldermalsen, D.M. Sharp, J.C. Tiffen, R.M. Ryan, M. Jormakka, N.K. Haass, J.E.J. Rasko, and J. Holst Targeting glutamine transport to suppress melanoma cell growth Int. J. Cancer 2014 10.1002/ijc.28749
89. C. Commisso, S.M. Davidson, R.G. Soydaner-Azeloglu, S.J. Parker, J.J. Kamphorst, S. Hackett, E. Grabocka, M. Nofal, J.A. Drebin, C.B. Thompson, J.D. Rabinowitz, C.M. Metallo, M.G. Vander Heiden, and D. Bar-Sagi Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells Nature 497 2013 633 637
90. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discov. 9 2010 615 627
91. G. Sahay, D.Y. Alakhova, and A.V. Kabanov Endocytosis of nanomedicines J. Control. Release 145 2010 182 195
92. S. Xu, B.Z. Olenyuk, C.T. Okamoto, and S.F. Hamm-Alvarez Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances Adv. Drug Deliv. Rev. 65 2013 121 138
93. C. Müller, and R. Schibli Prospects in folate receptor-targeted radionuclide therapy Front Oncol. 3 2013 249
94. P.S. Low, and S.A. Kularatne Folate-targeted therapeutic and imaging agents for cancer Curr. Opin. Chem. Biol. 13 2009 256 262
95. W. Xia, A.R. Hilgenbrink, E.L. Matteson, M.B. Lockwood, J.X. Cheng, and P.S. Low A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages Blood 113 2009 438 446
96. J.F. Ross, H. Wang, F.G. Behm, P. Mathew, M. Wu, R. Booth, and M. Ratnam Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia Cancer 85 1999 348 357 (Pubitemid 29051289)
97. P.S. Low, W.A. Henne, and D.D. Doorneweerd Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases Acc. Chem. Res. 41 2008 120 129
98. X. Zhao, H. Li, and R.J. Lee Targeted drug delivery via folate receptors Expert Opin. Drug Deliv. 5 2008 309 319 (Pubitemid 351454380)
99. A. Gabizon, D. Tzemach, J. Gorin, L. Mak, Y. Amitay, H. Shmeeda, and S. Zalipsky Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor expressing tumor models Cancer Chemother. Pharmacol. 66 2010 43 52
100. S. Jiang, X. Gong, X. Zhao, and Y. Zu Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles Drug Deliv. 2014 10.3109/10717544.2013.879964
101. M.E. Werner, S. Karve, R. Sukumar, N.D. Cummings, J.A. Copp, R.C. Chen, T. Zhang, and A.Z. Wang Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis Biomaterials 32 2011 8548 8554
102. Y. Lu, E. Sega, C.P. Leamon, and P.S. Low Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential Adv. Drug Deliv. Rev. 56 2004 1161 1176 (Pubitemid 38496513)
103. H. Li, Y. Lu, L. Piao, J. Wu, S. Liu, G. Marcucci, M. Ratnam, and R.J. Lee Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acid Int. J. Pharm. 402 2010 57 63
104. P. Ponka, and C.N. Lok The transferrin receptor: role in health and disease Int. J. Biochem. Cell Biol. 31 1999 1111 1137 (Pubitemid 29454549)
105. C. Schneider, M.J. Owen, D. Banville, and J.G. Williams Primary structure of human transferrin receptor deduced from the mRNA sequence Nature 311 1984 675 678 (Pubitemid 14000663)
106. M.B. Omary, and I.S. Trowbridge Biosynthesis of the human transferrin receptor in cultured cells J. Biol. Chem. 256 1981 12888 12892 (Pubitemid 12132929)
107. F. Sadat Tabatabaei Mirakabad, K. Nejati-Koshki, A. Akbarzadeh, M.R. Yamchi, M. Milani, N. Zarghami, V. Zeighamian, A. Rahimzadeh, S. Alimohammadi, Y. Hanifehpour, and S.W. Joo PLGA-based nanoparticles as cancer drug delivery systems Asian Pac. J. Cancer Prev. 15 2014 517 535
108. F. Danhier, O. Feron, and V. Préat To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Control. Release 148 2010 135 146
109. R. van der Meel, L.J.C. Vehmeijer, R.J. Kok, G. Storm, and E.V.B. van Gaal Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status Adv. Drug Deliv. Rev. 65 2013 1284 1298
110. C.H. Choi, C.A. Alabi, P. Webster, and M.E. Davis Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles Proc. Natl. Acad. Sci. U. S. A. 107 2010 1235 1240
111. Y. Cui, Q. Xu, P.K. Chow, D. Wang, and C.H. Wang Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment Biomaterials 34 2013 8511 8520
112. M. Hong, S. Zhu, Y. Jiang, G. Tang, and Y. Pei Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin J. Control. Release 133 2009 96 102
113. A. Salvati, A.S. Pitek, M.P. Monopoli, K. Prapainop, F.B. Bombelli, D.R. Hristov, P.M. Kelly, C. Åberg, E. Mahon, and K.A. Dawson Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface Nat. Nanotechnol. 8 2013 137 143
114. H. Mirghani, F. Amen, F. Moreau, J. Guigay, D.M. Hartl, and J. Lacau St Guily Oropharyngeal cancers: relationship between epidermal growth factor receptor alterations and human papillomavirus status Eur. J. Cancer 50 2014 1100 1111
115. T. Holbro, G. Civenni, and N.E. Hynes The ErbB receptors and their role in cancer progression Exp. Cell Res. 284 2003 99 110 (Pubitemid 36331969)
116. G. Lurje, and H.J. Lenz EGFR signaling and drug discovery Oncology 77 2009 400 410
117. R.C. Harris, E. Chung, and R.J. Coffey EGF receptor ligands Exp. Cell Res. 284 2003 2 13 (Pubitemid 36331964)
118. M.A. Shevtsov, B.P. Nikolaev, L.Y. Yakovleva, Y.Y. Marchenko, A.V. Dobrodumov, A.L. Mikhrina, M.G. Martynova, O.A. Bystrova, I.V. Yakovenko, and A.M. Ischenko Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors Int. J. Nanomedicine 9 2014 273 287
119. C.L. Tseng, W.Y. Su, K.C. Yen, K.C. Yang, and F.H. Lin The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation Biomaterials 30 2009 3476 3485
120. S. Acharya, F. Dilnawaz, and S.K. Sahoo Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy Biomaterials 30 2009 5737 5750
121. S.M. Lee, H. Park, J.W. Choi, Y.N. Park, C.O. Yun, and K.H. Yoo Multifunctional nanoparticles for targeted chemophotothermal treatment of cancer cells Angew. Chem. Int. Ed. Engl. 50 2011 7581 7586
122. A. Kol, A.G. Terwisscha van Scheltinga, H. Timmer-Bosscha, L.E. Lamberts, F. Bensch, E.G. de Vries, and C.P. Schröder HER3, serious partner in crime: therapeutic approaches and potential biomarkers for effect of HER3-targeting Pharmacol. Ther. 2014 10.1016/j.pharmthera.2014.01.005
123. A.K. Rajasekaran, G. Anilkumar, and J.J. Christiansen Is prostate-specific membrane antigen a multifunctional protein? Am. J. Physiol. Cell Physiol. 288 2005 C975 C981
124. N. Schülke, O.A. Varlamova, G.P. Donovan, D. Ma, J.P. Gardner, D.M. Morrissey, R.R. Arrigale, C. Zhan, A.J. Chodera, K.G. Surowitz, P.J. Maddon, W.D.W. Heston, and W.C. Olson The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy Proc. Natl. Acad. Sci. U. S. A. 100 2003 12590 12595 (Pubitemid 37339943)
125. G.C. Tucker Integrins: molecular targets in cancer therapy Curr. Oncol. Rep. 8 2006 96 103
126. K.E. Gottschalk, and H. Kessler The structures of integrins and integrin-ligand complexes: implications for drug design and signal transduction Angew. Chem. Int. Ed. 41 2002 3767 3774 (Pubitemid 35277998)
127. B.P. Eliceiri, and D.A. Cheresh The role of alpha v integrins during angiogenesis: insights into potential mechanisms of action and clinical development J. Clin. Invest. 103 1999 1227 1230 (Pubitemid 29218291)
128. P.C. Brooks, S. Stromblad, L.C. Sanders, T.L. von Schalscha, R.T. Aimes, W.G. Stetler-Stevenson, J.P. Quigley, and D.A. Cheresh Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 Cell 85 1996 683 693 (Pubitemid 26181048)
129. W. Arap, R. Pasqualini, and E. Ruoslahti Chemotherapy targeted to tumor vasculature Curr. Opin. Oncol. 10 1998 560 565 (Pubitemid 28502251)
130. S. Liu Radiolabeled cyclic RGD peptides as integrin αvβ3- targeted radiotracers: maximizing binding affinity via bivalency Bioconjug. Chem. 20 12 2009 2199 2213
131. L. Auzzas, F. Zanardi, L. Battistini, P. Burreddu, P. Carta, G. Rassu, C. Curti, and G. Casiraghi Targeting v3 integrin: design and applications of mono- and multifunctional RGD-based peptides and semipeptides Curr. Med. Chem. 17 2010 1255 1299
132. 3 integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug ACS Nano 6 2012 4530 4539
133. M.M. Borner, P. Schoffski, R. de Wit, F. Caponigro, G. Comella, A. Sulkes, G. Greim, G.J. Peters, K. van der Born, J. Wanders, R.F. de Boer, C. Martin, and P. Fumoleau Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer Eur. J. Cancer 38 2002 349 358 (Pubitemid 34121962)
134. M. Goldberg, and I. Gomez-Orellana Challenges for the oral delivery of macromolecules Nat. Rev. Drug Discov. 2 2003 289 295 (Pubitemid 37361687)
135. F.W. Brambell The transmission of immune globulins from the mother to the foetal and newborn young Proc. Nutr. Soc. 28 1969 35 41
136. E.M. Pridgen, F. Alexis, T.T. Kuo, E. Levy-Nissenbaum, R. Karnik, R.S. Blumberg, R. Langer, and O.C. Farokhzad Transepithelial transport of Fc-targeted nanoparticles by the neonatal Fc receptor for oral delivery Sci. Transl. Med. 5 2013 213ra167
137. L. Rajendran, H.-J. Knölker, and K. Simons Subcellular targeting strategies for drug design and delivery Nat. Rev. Drug Discov. 9 2010 29 42
138. O. Boussif, F. Lezoualc'h, M.A. Zanta, M.D. Mergny, D. Scherman, B. Demeneix, and J.P. Behr A versatile vector for gene and oligonuceotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl. Acad. Sci. U. S. A. 92 1995 7297 7301
139. E.N. Guidry, J. Farand, A. Soheili, C.A. Parish, N.J. Kevin, B. Pipik, K.B. Calati, N. Ikemoto, J.H. Waldman, A.H. Latham, B.J. Howell, A. Leone, R.M. Garbaccio, S.E. Barrett, R.G. Parmar, Q.T. Truong, B. Mao, I.W. Davies, S.L. Colletti, and L. Sepp-Lorenzino Improving the in vivo therapeutic index of siRNA polymer conjugates through increasing pH responsiveness Bioconjug. Chem. 25 2014 296 - 307 296 - 307
140. J.O. Agola, P.A. Jim, H.H. Ward, S. Basuray, and A. Wandinger-Ness Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities Clin. Genet. 80 2011 305 318
141. M.-P. Stein, J. Dong, and A. Wandinger-Ness Rab proteins and endocytic trafficking: potential targets for therapeutic intervention Adv. Drug Deliv. Rev. 55 2003 1421 1437 (Pubitemid 37464571)
142. X. Li, and M. DiFiglia The recycling endosome and its role in neurological disorders Prog. Neurobiol. 97 2012 127 141
143. R.A. Nixon, P.M. Mathews, and A.M. Cataldo The neuronal endosomal-lysosomal system in Alzheimer's disease J. Alzheimers Dis. 3 2001 97 107 (Pubitemid 32238256)
144. C.A. Walsh, E.M. Morrow, and J.L.R. Rubenstein Autism and brain development Cell 135 2008 396 400
145. Q. Ouyang, S.B. Lizarraga, M. Schmidt, U. Yan, J. Gong, D. Elisor, J.A. Kauer, and E.M. Morrow Christianson syndrome protein NHE6 modulates TrkB endosomal signaling required for neuronal circuit development Neuron 80 2013 97 112
146. J. Huotari, and A. Helenius Endosome maturation EMBO J. 30 2011 3481 3500
147. C.C. Yap, and B. Winckler Acid indigestion in the endosome: linking signaling dysregulation to neurodevelopmental disorders Neuron 80 2013 4 6
148. + exchangers: novel players in organelle pH regulation and their emerging functions Biochemistry 50 2011 443 450
149. B.A. Webb, M. Chimenti, M.P. Jacobson, and D.L. Barber Dysregulated pH: a perfect storm for cancer progression Nat. Rev. Cancer 11 2011 671 677
150. + exchanger in metastasis Nat. Rev. Cancer 5 2005 786 795 (Pubitemid 41400778)
151. S. Harguindey, J.L. Arranz, J.D.P. Orozco, C. Rauch, S. Fais, R.A. Cardone, and S.J. Reshkin Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs-an integral molecular/biochemical/ metabolic/clinical approach after one hundred years of cancer research J. Transl. Med. 11 2013 282 298
152. D. Neri, and C.T. Supuran Interfering with pH regulation in tumours as a therapeutic strategy Nat. Rev. Drug Discov. 10 2011 767 777
153. C. de Duve Lysosomes revisited Eur. J. Biochem. 137 1983 391 397 (Pubitemid 14206086)
154. N.H.T. Petersen, O.D. Olsen, L. Groth-Pedersen, A.-M. Ellegaard, M. Bilgin, S. Redmer, M.S. Ostenfeld, D. Ulanet, T.H. Dovmark, A. Lønborg, S.D. Vindeløv, D. Hanahan, C. Arenz, C.S. Ejsing, T. Kirkegaard, M. Rohde, J. Nylandsted, and M. Jäättelä Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase Cancer Cell 24 2013 379 393
155. Erich Gulbins, and Richard N. Kolesnick It takes a CAD to kill a tumor cell with a LMP Cancer Cell 24 2013 279 281
156. P. Saftig, K. Sandhoff, Cancer: Killing from the inside, Nature, 502, 312-313.
157. M. Kong, H. Park, X. Cheng, and X. Chen Spatial-temporal event adaptive characteristics of nanocarrier drug delivery in cancer therapy J. Control. Release 172 2013 281 291
158. R. Duncan, and S.C.W. Richardson Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges Mol. Pharm. 9 2012 2380 2402
159. C. Zheng, J. Xu, X. Yao, J. Xu, and L. Qiu Polyphosphazene nanoparticles for cytoplasmic release of doxorubicin with improved cytotoxicity against Dox-resistant tumor cells J. Colloid Interface Sci. 355 2011 374 382
160. H. Yu, Z. Xu, X. Chen, L. Xu, Q. Yin, Z. Zhang, and Y. Li Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel Macromol. Biosci. 14 2014 100 109
161. Yan Lee, Shigeto Fukushima, Younsoo Bae, Shigehiro Hiki, Takehiko Ishii, and Kazunori Kataoka A protein nanocarrier from charge-conversion polymer in response to endosomal pH J. Am. Chem. Soc. 129 2007 5362 5363 (Pubitemid 46697615)
162. S. Binauld, and M.H. Stenzel Acid-degradable polymers for drug delivery: a decade of innovation Chem. Commun. 49 2013 2082 2102
163. L. Zhu, T. Wang, F. Perche, A. Taigind, and V.P. Torchilin Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety Proc. Natl. Acad. Sci. U. S. A. 110 2013 17047 17052
164. K.N. Sugahara, T. Teesalu, P.P. Karmali, V.R. Kotamraju, L. Agemy, D.R. Greenwald, and E. Ruoslahti Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Science 328 2010 1031 1035
165. M.T. Tarragó-Trani, and B. Storrie Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum Adv. Drug Deliv. Rev. 59 2007 782 797 (Pubitemid 47320814)
166. K. Sandvig, J. Bergan, A.B. Dyve, T. Skotland, and M.L. Torgersen Endocytosis and retrograde transport of Shiga toxin Toxicon 56 2010 1181 1185
167. B.G. Bitler, A. Goverdhan, and J.A. Schroeder MUC1 regulates nuclear localization and function of the epidermal growth factor receptor J. Cell Sci. 123 2010 1716 1723
168. H. Yoshida ER stress and diseases FEBS J. 274 2007 630 658 (Pubitemid 46150855)
169. T. Minamino, I. Komuro, and M. Kitakaze Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease Circ. Res. 107 2010 1071 1082
170. X. Leleu, L. Xu, X. Jia, A. Sacco, M. Farag, Z.R. Hunter, A.S. Moreau, H.T. Ngo, E. Hatjiharissi, A.W. Ho, D.D. Santos, S. Adamia, K. O'Connor, B. Ciccarelli, J. Soumerai, R.J. Manning, C.J. Patterson, A.M. Roccaro, I.M. Ghobrial, and S.P. Treon Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia Blood 113 2009 626 634
171. M.S. Cartieraa, K.M. Johnsona, V. Rajendranb, M.J. Caplanb, and W.M. Saltzmana The uptake and intracellular fate of PLGA nanoparticles in epithelial cells Biomaterials 30 2009 2790 2798
172. T. Chernenko, C. Matthäus, L. Milane, L. Quintero, M. Amiji, and M. Diem Label-free Raman spectral imaging of intracellular delivery and degradation of polymeric nanoparticle systems ACS Nano 3 2009 3552 3559
173. B. He, Z. Jia, W. Du, C. Yu, Y. Fan, W. Dai, L. Yuan, H. Zhang, X. Wang, J. Wang, X. Zhang, and Q. Zhang The transport pathways of polymer nanoparticles in MDCK epithelial cells Biomaterials 34 2013 4309 4326
174. L. Galluzzi, G. Kroemer, and S. Fulda Targeting mitochondria for cancer therapy Nat. Rev. Drug Discov. 9 2010 447 464
175. I.J. Holt, A.E. Harding, and J.A. Morgan-Hughes Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies Nature 331 1988 717 719 (Pubitemid 18062238)
176. Y. Yamada, H. Akita, K. Kogure, H. Kamiya, and H. Harashima Mitochondrial drug delivery and mitochondrial disease therapy - an approach to liposome-based delivery targeted to mitochondria Mitochondrion 7 2007 63 71 (Pubitemid 46351977)
177. E.A. Schon, and S. DiMauro Medicinal and genetic approaches to the treatment of mitochondrial disease Curr. Med. Chem. 10 2003 2523 2533 (Pubitemid 37456023)
178. D.C. Wallace Mitochondrial diseases in man and mouse Science 283 1999 1482 1488
179. Y. Yamada, and H. Harashima Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases Adv. Drug Deliv. Rev. 60 2008 1439 1462
180. S.R. Jean, D.V. Tulumello, S.P. Wisnovsky, E.K. Lei, M.P. Pereira, and S.O. Kelley Molecular vehicles for mitochondrial chemical biology and drug delivery ACS Chem. Biol. 9 2014 323 333
181. R.A.J. Smith, R.C. Hartley, and M.P. Murphy Mitochondria-targeted small molecule therapeutics and probes Antioxid. Redox Signal. 15 2011 3021 3038
182. M.P. Murphy Targeting lipophilic cations to mitochondria Biochim. Biophys. Acta 1777 2008 1028 1031
183. C. Reily, T. Mitchell, B.K. Chacko, G.A. Benavides, M.P. Murphy, and V.M. Darley-Usmar Mitochondrially targeted compounds and their impact on cellular bioenergetics Redox Biol. 1 2013 86 93
184. E.A. Liberman, V.P. Topaly, L.M. Tsofina, A.A. Jasaitis, and V.P. Skulachev Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria Nature 222 1969 1076 1078
185. B.H. Kang, J. Plescia, H.Y. Song, M. Meli, G. Colombo, K. Beebe, B. Scroggins, L. Neckers, and D.C. Altieri Combinatorial drug design targeting multiple cancer signaling networks controlled J. Clin. Invest. 119 2009 454 464
186. V.J. Adlam, J.C. Harrison, C.M. Porteous, A.M. James, R.A. Smith, M.P. Murphy, and I.A. Sammut Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury FASEB J. 19 2005 1088 1095 (Pubitemid 40946434)
187. S. Chalmers, S.T. Caldwell, C. Quin, T.A. Prime, A.M. James, A.G. Cairns, M.P. Murphy, J.G. McCarron, and R.C. Hartley Selective uncoupling of individual mitochondria within a cell using a mitochondria-targeted photoactivated protonophore J. Am. Chem. Soc. 134 2012 758 761
188. R.A. Smith, C.M. Porteous, A.M. Gane, and M.P. Murphy Delivery of bioactive molecules to mitochondria in vivo Proc. Natl. Acad. Sci. U. S. A. 100 2003 5407 5412 (Pubitemid 36542718)
189. S.V. Boddapati, P. Tongcharoensirikul, R.N. Hanson, G.G. D'Souza, V.P. Torchilin, and V. Weissig Mitochondriotropic liposomes J. Liposome Res. 15 2005 49 58 (Pubitemid 40976306)
190. N.R. Patel, S. Hatziantoniou, A. Georgopoulos, C. Demetzos, V.P. Torchilin, V. Weissig, and G.G. D'Souza Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol J. Liposome Res. 20 2010 244 249
191. S.V. Boddapati, G.G. D'Souza, S. Erdogan, V.P. Torchilin, and V. Weissig Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo Nano Lett. 8 2008 2559 2563
192. Y. Yamada, and H. Harashima Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter Biomaterials 33 2012 1589 1595
193. I.A. Khalil, K. Kogure, S. Futaki, and H. Harashima High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression J. Biol. Chem. 281 2006 3544 3551 (Pubitemid 43845971)
194. Y. Yamada, H. Akita, H. Kamiya, K. Kogure, T. Yamamoto, Y. Shinohara, K. Yamashita, H. Kobayashi, H. Kikuchi, and H. Harashima MITO-Porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion Biochim. Biophys. Acta 1778 2008 423 432
195. S. Biswas, N.S. Dodwadkar, P.P. Deshpande, and V.P. Torchilin Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo J. Control. Release 159 2012 393 402
196. S. Marrache, and S. Dhar Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics PNAS 109 2012 16288 16293
197. X.-H. Wang, H.-S. Peng, L. Yang, F.-T. You, F. Teng, A.-W. Tang, F.-J. Zhang, and X.-H. Li Poly-l-lysine assisted synthesis of core-shell nanoparticles and conjugation with triphenylphosphonium to target mitochondria J. Mater. Chem. B 1 2013 5143 5152
198. J. Shi, J.L. Choi, B. Chou, R.N. Johnson, J.G. Schellinger, and S.H. Pun Effect of polyplex morphology on cellular uptake, intracellular trafficking, and transgene expression ACS Nano 7 2013 10612 10620
199. A. Ferrari, V. Pellegrini, C. Arcangeli, A. Fittipaldi, M. Giacca, and Fabio Beltram A caveolae-mediated internalization of extracellular HIV-1 Tat fusion proteins visualized in real time Mol. Ther. 8 2003 284 294 (Pubitemid 37062838)
200. L.A. Carver, and J.E. Schnitzer Caveolae: mining little caves for new cancer targets Nat. Rev. Cancer 3 2003 571 581 (Pubitemid 37328829)
201. M.J. Reilly, J.D. Larsen, and M.O. Sullivan Polyplexes traffic through caveolae to the Golgi and endoplasmic reticulum en route to the nucleus Mol. Pharm. 9 2012 1280 1290
202. H. Li, T. Luo, R. Sheng, J. Sun, Z. Wang, and A. Cao Endoplasmic reticulum localization of poly(ω-aminohexyl methacrylamide)s conjugated with (l-)-arginines in plasmid DNA delivery Biomaterials 34 2013 7923 7938
203. K.M. Fichter, N.P. Ingle, P.M. McLendon, and T.M. Reineke Polymeric nucleic acid vehicles exploit active interorganelle trafficking mechanisms ACS Nano 7 2013 347 364
204. H.-J. Liao, and G. Carpenter Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression Mol. Biol. Cell 18 2007 1064 1072 (Pubitemid 46399509)
205. T.-L.L. Chen, P.Y. Wang, W. Luo, S.S. Gwon, N.W. Flay, J. Zheng, C. Guo, M.L. Tanzer, and B.M. Vertel Aggrecan domains expected to traffic through the exocytic pathway are misdirected to the nucleus Exp. Cell Res. 263 2001 224 235 (Pubitemid 32989096)
206. H.Y. Nam, S.M. Kwon, H. Chung, S.-Y. Lee, S.-H. Kwon, H. Jeon, Y. Kim, J.H. Park, J. Kim, S. Her, Y.-K. Oh, I.C. Kwon, K. Kim, and S.Y. Jeong Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles J. Control. Release 135 2009 259 267
207. L.J. Terry, E.B. Shows, and S.R. Wente Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport Science 318 2007 1412 1416 (Pubitemid 350208921)
208. F.-Y. Cheng, S.P.-H. Wang, C.-H. Su, T.-L. Tsai, P.-C. Wu, D.-B. Shieh, J.-H. Chen, P.C.-H. Hsieh, and Chen-Sheng Yeh Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes Biomaterials 29 2008 2104 2112
209. R. Misra, and S.K. Sahoo Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy Eur. J. Pharm. Sci. 39 2010 152 163
210. B. Hoang, R.M. Reilly, and C. Allen Block copolymer micelles target auger electron radiotherapy to the nucleus of HER2-positive breast cancer cells Biomacromolecules 13 2012 455 465
211. J. Yu, X. Xie, X. Xu, L. Zhang, X. Zhou, H. Yu, P. Wu, T. Wang, X. Che, and Z. Hu Development of dual ligand-targeted polymeric micelles as drug carriers for cancer therapy in vitro and in vivo J. Mater. Chem. B 2 2014 2114 2126